Metabolic & Cardiometabolic · Gut & Microbiome
metabolic endotoxemia (LPS) causes GLP-1 resistance
In plain terms: Does gut inflammation blunt the appetite/blood-sugar hormone GLP-1?
Probably modestly yes — inflammation seems to dampen the hormone's signal, but this is shown mainly in animals and the lab.
📅 Last reviewed: 2026-07-15 ⓘ
Evidence ladder
How far up the ladder this claim has climbed. A high consensus on a low rung means "consistent so far," not "proven in people."
Top evidence so far: Animal studies (Animal)
How the studies fall
What the evidence shows
Inflammation/LPS blunts GLP-1 signaling two ways: impaired FXR/TGR5-mediated secretion, and GLP-1-RECEPTOR silencing via promoter hypermethylation (DNMT3A/3B). 'GLP-1 resistance' is ligand- and receptor-side. Animal/mechanism-grade.
The evidence (13)
| Source | Grade | Stance | Quality | Finding |
|---|---|---|---|---|
| Deng et al. 2026 · Biochem Pharmacol | in-vitro | supports | moderate | [FT-verified] LPS->DNMT3->GLP-1R promoter hypermethylation->reduced receptor (resistance mechanism) ⚠️ correction-on-file (Crossref) - kept, corrigendum not retraction |
| Cani 2007 · Diabetes | animal | supports | high | Foundational: metabolic endotoxemia (LPS infusion/HFD) initiates obesity and insulin resistance and disrupts the gut-incretin metabolic milieu in mice |
| Balogun O et al 2026 · Nutrients | animal | supports | moderate | Rodent (HFD-fed mice) model: quercetin restored intestinal barrier integrity, reducing plasma LPS by 36% and increasing GLP-1 by 23% versus HFD-alone controls. Shows an inverse LPS-GLP-1 relationship consistent with LPS suppressing GLP-1 se |
| Kishida 2017 · J Gastroenterol | animal | mixed | low | Miglitol increased GLP-1 and suppressed endotoxemia in NASH model; reciprocal link supports endotoxemia impairing the GLP-1 axis |
| Ahn 2017 · Diabetes Obes Metab | RCT | mixed | moderate | DPP4 inhibitor gemigliptin reduced postprandial ApoB48 in T2DM but whether systemic endotoxin is lowered remained inconclusive |
| Long et al. 2026 · Front Endocrinol | mechanism | mixed | low | Endotoxemia -> impaired FXR/TGR5-mediated GLP-1 secretion (gut-immune-metabolic axis) |
| Nakamori 2024 · J Physiol | animal | contradicts | moderate | Luminal LPS stimulates GLP-1 release from colonic L cells via TLR4 (LPS raises, not blunts, GLP-1) |
| Anhe 2021 · Cell Rep | animal | supports | high | Metabolic endotoxemia effect dictated by LPS lipid-A acylation; LPS structure drives inflammatory/metabolic (incl incretin-axis) dysfunction in obese mice |
| Wongkrasant 2020 · J Pharmacol Sci | animal | supports | moderate | Intestinal inflammation drove L-cell apoptosis via NF-kB-iNOS-caspase-3 lowering GLP-1; FOS rescued GLP-1 levels, evidencing inflammation-impaired GLP-1 |
| Lebrun 2017 · Cell Rep | animal | contradicts | moderate | [FT-verified] acute LPS RAISES GLP-1 via TLR4 (mice+humans) - opposite of secretory resistance |
| Zong 2022 · Int J Mol Sci | animal | mixed | low | Salmonella/endotoxin lowers blood GLP-1 by triggering enteroendocrine L-cell pyroptosis |
| Oh 2015 · Obes Surg | animal | supports | moderate | Ileal transposition lowered plasma LPS and raised L-cell secretion with improved insulin sensitivity, implying endotoxemia suppresses GLP-1 output |
| Wang 2023 · Nat Metab | animal | supports | high | Total parenteral nutrition altered gut microbiota/metabolites impairing glucose metabolism; a GLP-1 receptor agonist fully prevented the disorder |
Disagree, or know a study we missed?
We grade by evidence, not opinions. The way to weigh in is to point us to a study we haven't cited (check the evidence table above first), or to flag a problem with one we have. Every submission is reviewed; if it holds up, the grade updates and shows in Science Changes Its Mind.
Opens a short form. You'll sign in with Google so submissions are tied to a real account — we don't display your identity, and we only accept a link we can verify (PubMed, DOI, ClinicalTrials.gov).
Educational only, not medical advice. Grades and scores reflect published evidence weighted by study design and quality; see the methodology.